Helius Medical Technologies Operating Income

The latest operating income for HSDT is $-370M as of June 2026. That compares with $-15M in the prior-year period — down 2434.7% year over year. Investors often review this figure alongside Helius Medical Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, HSDT's operating income moved from $-15M to $-370M — a 2434.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Helius Medical Technologies's operating scale or balance-sheet position.

A operating income figure of $-370M for HSDT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting HSDT's operating income ($-370M), review year-over-year change from $-15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Helius Medical Technologies's operating income against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.